pdf/GLP.PDF

Tests for the best
Advanced Product Guide
Press
News
Portfolio Update
FAQ
Information & Services
Contact


Newsletter  Newsletter
    Information & Services

    Downloads

  • Company Information
  • Flyers
  • Discovery Lead Optimisation Services
  • Pharmacokinetics /Pharmacodynamics - Bioanalytics
  • Target Based Bioassays in vitro and in vivo
  • Test sequence


  • Physico-chemical parameters
  • Aqueous solubility
  • Chemical stability (specific assay conditions)
  • Lipophilicity by CHI

  • ADMET
  • Metabolic stability determination in vitro (various species)
  • Microsomes (Phase I and/or glucuronidation, various species)
  • Hepatocytes (various species)
  • Metabolite identification and characterisation (in vitro or ex vivo)
  • P450 profiling
  • Rapid screen (recombinantly expressed single P450 enzymes)
  • Probe substrate approach with microsomes (meets FDA guidelines)
  • P450 inhibition
  • Evaluation of direct and metabolism- dependent inhibition of Cytochrome P450 enzymes
  • Rapid screen (recombinantly expressed single P450 enzymes)
  • Probe substrate approach with liver microsomes (meets FDA guidelines)
  • P450 induction
  • Metabolism assay in HepaRG cell line
  • Plasma, serum or blood stability
  • Permeability screen in vitro on artificial membranes
  • PAMPA (prediction of intestinal absorption)
  • BBB (prediction of CNS penetration)
  • Permeability screen in vitro on Caco2 cell monolayers
  • Pgp affinity (bidirectional transport in Caco2)
  • Pgp inhibition (ATPase assay)
  • Plasma or serum protein binding
  • Determination of Kd for HSA and AGP
  • In vitro cytotoxicity
  • Histamine release ex vivo in rat mastocytes


  • In vivo Pharmacokinetics
  • Cassette dosing
  • Cassette analysing
  • Single in vivo PK
  • Metabolism and excretion

  • Biomarkers and immunochemistry
  • Immunoassays

  • Steroid endocrinology
  • Aromatase inhibitors
  • In vitro
  • In vivo
  • Aromatase test sequence
  • Selectivity (ex vivo)
  • Aldosterone synthase inhibitors
  • In vivo
  • P450 17 inhibitors
  • In vitro
  • In vivo
  • Selectivity (in vitro)
  • CYP17 test sequence
  • 5-alpha-reductase Inhibitors
  • In vitro
  • In vivo
  • GnRH agonists/antagonists
  • In vitro
  • In vivo
  • Pre-selection
  • GnRH test sequence
  • PK/PD relationship
  • Estrogens/anti-estrogens

  • Metabolic syndrome
  • Obesity
  • Diabetes type II
  • In vitro GLP-1 receptor assay
  • In vivo rat diabetes model
  • In vivo murine diabetes model
  • Food intake/weight gain studies

  • Cytotoxicity / Toxicology Screening
  • TOX-ESCAPE
  • Live-Cell Toxicology Screening Platform
  • Toxicology and Preclinical Development Unit
  • Flow Cytometry
  • Reactive oxygen species (ROS)
  • Apoptosis
  • Immunological effects
  • Membrane integrity
  • Cell cycle distribution
  • S-phase content
  • Regulatory Genotoxicity Test
  • Anti-Inflammatory Cytokine Response
  • In vitro cytotoxicity extrapolation for estimation of in vivo LD50
  • Mitochondrial Transmembrane Potential
  • Intracellular Calcium Level